Literature DB >> 27187520

Open compared with laparoscopic complete mesocolic excision with central lymphadenectomy for colon cancer: a systematic review and meta-analysis.

C D Athanasiou1, G A Markides1, A Kotb1, X Jia1, S Gonsalves1, D Miskovic1,2.   

Abstract

AIM: Several studies report improved survival in colon cancer with use of extended lymphadenectomy techniques (ELTs), such as D3 lymphadenectomy or complete mesocolic excision. The noninferiority of laparoscopic versus open techniques has already been established in D2 resections. The aim of this study was to compare the safety and efficacy of open and laparoscopic approaches for ELTs in colon cancer.
METHOD: Major databases, including PubMed, Scopus and the Cochrane library, were searched using defined inclusion and exclusion criteria, and relevant data were extracted. The Cochrane and Newcastle-Ottawa tools were used for critical appraisal and quality assessment. Meta-analysis with various subgroup analyses were undertaken, and clinical and statistical heterogeneity, along with publication bias, were also assessed.
RESULTS: One randomized and seven case-control trials were included. All studies were found to be of low methodological quality with some external validity issues. There was no difference in short-term mortality [OR = 2.16 (95% CI: 0.73-6.41); P = 0.16], anastomotic leakage, ileus or deep-sited infection/abscess. There was a trend for longer operative time [weighted mean difference (WMD) = -30.88 (95% CI: -62.38 to 0.61); P = 0.05] and shorter length of hospital stay [WMD = 2.29 (95% CI: -0.39 to 4.98); P = 0.09] with the laparoscopic approach. Laparoscopic right hemicolectomy had a lower wound-infection rate [OR = 2.87 (95% CI: 1.38-5.98); P = 0.005] compared with the relevant open group. No statistically significant difference was found in overall survival [hazard ratio (HR) = 0.85 (95% CI: 0.69-1.06); P = 0.15], disease-free survival, local recurrence and distant metastases.
CONCLUSION: Based on the current evidence, the laparoscopic technique appears to be at least as safe as the open technique when used in performing ELTs for colonic cancer, with similar morbidity and oncological outcomes. Colorectal Disease
© 2016 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  CME/D3; colonic cancer; extended lymphadenectomy techniques

Mesh:

Year:  2016        PMID: 27187520     DOI: 10.1111/codi.13385

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  15 in total

1.  Laparoscopic Complete Mesocolic Excision for Right-Sided Colon Cancer: Analysis of Feasibility and Safety from a Single Western Center.

Authors:  Corrado Pedrazzani; Enrico Lazzarini; Giulia Turri; Eduardo Fernandes; Cristian Conti; Valeria Tombolan; Filippo Nifosì; Alfredo Guglielmi
Journal:  J Gastrointest Surg       Date:  2018-11-14       Impact factor: 3.452

2.  Laparoscopic Versus Open Complete Mesocolon Excision in Right Colon Cancer: A Systematic Review and Meta-Analysis.

Authors:  Mohamed Ali Chaouch; Mohamed Wejih Dougaz; Ibtissem Bouasker; Hichem Jerraya; Wafa Ghariani; Mehdi Khalfallah; Ramzi Nouira; Chadli Dziri
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

3.  Comparison of Postoperative and Oncologic Outcomes in Laparoscopic and Open Right Colectomy for Colon Cancer: A 5-year Experience.

Authors:  Effrosyni Stavrou; Nikolaos Tzanakis; Eleftherios Spartalis; Dimitrios Patsouras; Konstantinos Georgiou; Georgios Tsourouflis; Dimitrios Dimitroulis; Nikolaos Nikiteas
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

Review 4.  The Mesentery in Complete Mesocolic Excision.

Authors:  Jordan Fletcher; Danilo Miskovic
Journal:  Clin Colon Rectal Surg       Date:  2022-08-10

5.  Robotic or three-dimensional (3D) laparoscopy for right colectomy with complete mesocolic excision (CME) and intracorporeal anastomosis? A propensity score-matching study comparison.

Authors:  Graziano Ceccarelli; Gianluca Costa; Valentina Ferraro; Michele De Rosa; Fabio Rondelli; Walter Bugiantella
Journal:  Surg Endosc       Date:  2020-05-05       Impact factor: 4.584

6.  Robotic complete mesocolic excision versus conventional robotic right colectomy for right-sided colon cancer: a comparative study of perioperative outcomes.

Authors:  José Tomás Larach; Julie Flynn; Timothy Wright; Amrish K S Rajkomar; Jacob J McCormick; Joseph Kong; Philip J Smart; Alexander G Heriot; Satish K Warrier
Journal:  Surg Endosc       Date:  2021-04-12       Impact factor: 4.584

7.  Laparoscopic versus open right hemicolectomy in colon carcinoma: A propensity score analysis of the DGAV StuDoQ|ColonCancer registry.

Authors:  Christian Jurowich; Sven Lichthardt; Caroline Kastner; Imme Haubitz; Andre Prock; Jörg Filser; Christoph-Thomas Germer; Armin Wiegering
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

8.  Transitional impact of short- and long-term outcomes of a randomized controlled trial to evaluate laparoscopic versus open surgery for colorectal cancer from Japan Clinical Oncology Group Study JCOG0404.

Authors:  Shoichi Fujii; Tomonori Akagi; Masafumi Inomata; Hiroshi Katayama; Junki Mizusawa; Mitsuyoshi Ota; Shuji Saito; Yusuke Kinugasa; Shigeki Yamaguchi; Takeo Sato; Seigo Kitano
Journal:  Ann Gastroenterol Surg       Date:  2019-03-26

Review 9.  Recent updates in the surgical treatment of colorectal cancer.

Authors:  Takeru Matsuda; Kimihiro Yamashita; Hiroshi Hasegawa; Taro Oshikiri; Masayoshi Hosono; Nobuhide Higashino; Masashi Yamamoto; Yoshiko Matsuda; Shingo Kanaji; Tetsu Nakamura; Satoshi Suzuki; Yasuo Sumi; Yoshihiro Kakeji
Journal:  Ann Gastroenterol Surg       Date:  2018-02-15

10.  Laparoscopic modified mesocolic excision with central vascular ligation in right-sided colon cancer shows better short- and long-term outcomes compared with the open approach in propensity score analysis.

Authors:  Jung Kyong Shin; Hee Cheol Kim; Woo Yong Lee; Seong Hyeon Yun; Yong Beom Cho; Jung Wook Huh; Yoon Ah Park; Ho-Kyung Chun
Journal:  Surg Endosc       Date:  2017-11-03       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.